Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02066545 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris
A Phase 2 study, sponsored by Maruho Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 327
- Enrollment target
NCT02066545: Completed Phase 2 study, sponsored by Maruho Co..
NCT02066545 is a Phase 2 study that has completed, run by Maruho Co.. The registered enrollment target is 327 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (146% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02066545, a Phase 2 study, has completed, sponsored by Maruho Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 327 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety and efficacy of once-daily topical application of CLS001 1%, 1.75% and 2.5% topical gel compared to vehicle topical gel in subjects with inflammatory acne vulgaris
Interventions
- DRUG CLS001 Topical Gel
- DRUG CLS001 Topical Gel Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2014-04 |
| Phase | Phase 2 |
What the finished NCT02066545 record still lists
NCT02066545 is an interventional study that assigns participants to a tested intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (146% higher).
The record links to 0 conditions, and to 2 interventions - of which CLS001 Topical Gel is the first listed.
NCT02066545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02066545 about?
NCT02066545 is a clinical study titled "Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris". The primary objective of this study is to evaluate the safety and efficacy of once-daily topical application of CLS001 1%, 1.75% and 2.5% topical gel compared to vehicle topical gel in subjects with inflammatory acne vulgaris
What is the current status of trial NCT02066545?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 327 participants. The study started on 2014-04.
What interventions are being tested in trial NCT02066545?
The interventions under investigation include: CLS001 Topical Gel (DRUG), CLS001 Topical Gel Vehicle (DRUG).
Who is sponsoring clinical trial NCT02066545?
This trial is sponsored by Maruho Co., which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02066545's enrollment target sits among peer trials
327 146th of 2000 higher than 1,854 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- NCT06370182 · 327 participants · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia